BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer. 1999;80:309-313. [PMID: 10390013 DOI: 10.1038/sj.bjc.6690356] [Cited by in Crossref: 195] [Cited by in F6Publishing: 205] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Dorp F, Wullich B, Gulbins E, Eisenhardt A. Molekularbiologische Erklärungsansätze einer Lymphknotenmetastasierung. Urologe [A] 2005;44:608-13. [DOI: 10.1007/s00120-005-0833-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Auvinen MI, Sihvo EI, Ruohtula T, Salminen JT, Koivistoinen A, Siivola P, Rönnholm R, Rämö JO, Bergman M, Salo JA. Incipient Angiogenesis in Barrett’s Epithelium and Lymphangiogenesis in Barrett’s Adenocarcinoma. JCO 2002;20:2971-9. [DOI: 10.1200/jco.2002.09.011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
3 He W, Tang B, Yang D, Li Y, Song W, Cheang T, Chen X, Li Y, Chen L, Zhan W, Li W, He Y. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients. World J Surg Oncol 2013;11:161. [PMID: 23866030 DOI: 10.1186/1477-7819-11-161] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
4 Nakaya H, Kawashiri S, Tanaka A, Noguchi N, Kato K, Hase T, Yamamoto E. Influences of angiogenesis and lymphangiogenesis on cancerous invasion in experimentally induced tongue carcinoma. J Oral Pathol Med 2005;34:87-92. [DOI: 10.1111/j.1600-0714.2004.00279.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
5 Lei Y, Li B, Tong S, Qi L, Hu X, Cui Y, Li Z, He W, Zu X, Wang Z, Chen M. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells. PLoS One 2015;10:e0117809. [PMID: 25658842 DOI: 10.1371/journal.pone.0117809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
6 Koyama Y, Kaneko K, Akazawa K, Kanbayashi C, Kanda T, Hatakeyama K. Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor-D mRNA Expression in Breast Cancer: Association with Lymph Node Metastasis. Clinical Breast Cancer 2003;4:354-60. [DOI: 10.3816/cbc.2003.n.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
7 Shin WS, Rockson SG. Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci 2008;1131:50-74. [PMID: 18519959 DOI: 10.1196/annals.1413.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
8 Van Trappen PO, Ryan A, Carroll M, Lecoeur C, Goff L, Gyselman VG, Young BD, Lowe DG, Pepper MS, Shepherd JH, Jacobs IJ. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer 2002;87:537-44. [PMID: 12189553 DOI: 10.1038/sj.bjc.6600471] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
9 Morita H, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Nishimura C, Igarashi Y, Miki K, Ishii T. Histopathological predictor for regional lymph node metastasis in gastric cancer. Virchows Arch. 2009;454:143-151. [PMID: 19104832 DOI: 10.1007/s00428-008-0717-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
10 Chen JC, Chang YW, Hong CC, Yu YH, Su JL. The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci 2012;14:88-107. [PMID: 23344023 DOI: 10.3390/ijms14010088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
11 Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Harkonen PL. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 2002;98:946-951. [PMID: 11948478 DOI: 10.1002/ijc.10283] [Cited by in Crossref: 169] [Cited by in F6Publishing: 147] [Article Influence: 8.9] [Reference Citation Analysis]
12 Ohta Y, Nozawa H, Tanaka Y, Oda M, Watanabe Y. Increased vascular endothelial growth factor and vascular endothelial growth factor–c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage i non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2000;119:804-13. [DOI: 10.1016/s0022-5223(00)70017-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
13 Esenwein SA, Martin D, Kuhnen C, Reimer R, Muhr G. [Retrogastral located gastrointestinal stromal tumor (GIST) as a sonographically detected rare incidental finding]. Zentralbl Chir. 2002;127:322-325. [PMID: 16843872 DOI: 10.1055/s-2002-31561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Kozakowski N, Hartmann C, Klingler HC, Susani M, Mazal PR, Scharrer A, Haitel A. Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment. Target Oncol 2014;9:359-66. [PMID: 24243494 DOI: 10.1007/s11523-013-0298-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, Wang F, Tucker S, Zhong B, Wang D. Expression of VEGF-C Correlates with a Poor Prognosis Based on Analysis of Prognostic Factors in 73 Patients with Esophageal Squamous Cell Carcinomas. Japanese Journal of Clinical Oncology 2009;39:644-50. [DOI: 10.1093/jjco/hyp079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
16 Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol. 2004;40:13-20. [PMID: 14662410 DOI: 10.1016/s1368-8375(03)00127-1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
17 Azzali G. Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate. Am J Pathol 2007;170:334-46. [PMID: 17200205 DOI: 10.2353/ajpath.2007.060447] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
18 Masłowska K, Halik PK, Tymecka D, Misicka A, Gniazdowska E. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy. Cancers (Basel) 2021;13:1072. [PMID: 33802353 DOI: 10.3390/cancers13051072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li Y, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int 2006;56:256-61. [DOI: 10.1111/j.1440-1827.2006.01961.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
20 Miyata Y, Nakamura Y, Yasuda T, Matsuo T, Ohba K, Furusato B, Fukuoka J, Sakai H. Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters. Prostate 2017;77:1408-15. [PMID: 28845514 DOI: 10.1002/pros.23402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ogawa E, Takenaka K, Yanagihara K, Kurozumi M, Manabe T, Wada H, Tanaka F. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer. 2004;91:498-503. [PMID: 15226767 DOI: 10.1038/sj.bjc.6601992] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
22 Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M, Patel HR. The metastatic cascade in prostate cancer. Surgical Oncology 2006;15:117-28. [DOI: 10.1016/j.suronc.2006.10.002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 5.0] [Reference Citation Analysis]
23 George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, Swift RI. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 2001;3:420-7. [PMID: 11687953 DOI: 10.1038/sj.neo.7900186] [Cited by in Crossref: 136] [Cited by in F6Publishing: 115] [Article Influence: 7.2] [Reference Citation Analysis]
24 Nassar ZD, Moon H, Duong T, Neo L, Hill MM, Francois M, Parton RG, Parat MO. PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis. Oncotarget 2013;4:1844-55. [PMID: 24123650 DOI: 10.18632/oncotarget.1300] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
25 Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Br J Cancer. 2006;95:75-79. [PMID: 16755294 DOI: 10.1038/sj.bjc.6603209] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
26 Herbst RS, Onn A, Mendelsohn J. The role of growth factor signaling in malignancy. Cancer Treat Res 2003;115:19-72. [PMID: 12613192 DOI: 10.1007/0-306-48158-8_2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
27 Al-rawi MA, Jiang WG. Lymphangiogenesis and metastatic spread of breast cancer. In: Mansel RE, Fodstad O, Jiang WG, editors. Metastasis of Breast Cancer. Dordrecht: Springer Netherlands; 2007. pp. 219-40. [DOI: 10.1007/978-1-4020-5867-7_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Yokoyama Y, Sato S, Futagami M, Fukushi Y, Sakamoto T, Umemoto M, Saito Y. Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma. Gynecologic Oncology 2000;77:413-8. [DOI: 10.1006/gyno.2000.5802] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
29 Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol. 2003;30:23-29. [PMID: 16843872 DOI: 10.1016/S0093-7754(03)00229-X] [Cited by in Crossref: 57] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
30 Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY, Zhang H. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol 2013;94:39-46. [PMID: 23317352 DOI: 10.1111/iep.12005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
31 Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205. [PMID: 11175851 DOI: 10.1038/84651] [Cited by in Crossref: 510] [Cited by in F6Publishing: 473] [Article Influence: 25.5] [Reference Citation Analysis]
32 Wang Z, Yu Y, Ma J, Zhang H, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. LyP-1 Modification To Enhance Delivery of Artemisinin or Fluorescent Probe Loaded Polymeric Micelles to Highly Metastatic Tumor and Its Lymphatics. Mol Pharmaceutics 2012;9:2646-57. [DOI: 10.1021/mp3002107] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
33 Borecký J, Maia IG, Arruda P. Mitochondrial uncoupling proteins in mammals and plants. Biosci Rep. 2001;21:201-212. [PMID: 16843872 DOI: 10.1023/A:1013604526175] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Liu H, Xiao J, Yang Y, Liu Y, Ma R, Li Y, Deng F, Zhang Y. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res 2011;82:131-40. [PMID: 21600223 DOI: 10.1016/j.mvr.2011.04.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
35 Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Current opinion on bevacizumab on endometrial cancer treatment. Expert Opin Biol Ther 2015;15:299-307. [PMID: 25539414 DOI: 10.1517/14712598.2015.995624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
36 Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, Alken P, Michel MS. The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int. 2006;98:903-906. [PMID: 16978291 DOI: 10.1111/j.1464-410X.2006.06403.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Kishimoto K, Sasaki A, Yoshihama Y, Mese H, Tsukamoto G, Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol. 2003;39:391-396. [PMID: 12676260 DOI: 10.1016/s1368-8375(02)00143-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
38 Okumura T, Tanno S, Ohhira M, Nozu T. The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan. Rheumatol Int. 2012;32:1695-1699. [PMID: 21431946 DOI: 10.1007/s00296-011-1849-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
39 Williams CS, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, Jackson DG. Absence of lymphangio-genesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol. 2003;200:195-206. [PMID: 12754740 DOI: 10.1002/path.1343] [Cited by in Crossref: 136] [Cited by in F6Publishing: 124] [Article Influence: 7.6] [Reference Citation Analysis]
40 Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-beltran A, Zhang S, Badve S, Baldridge LA, Montironi R. Lymphatic vessel density in radical prostatectomy specimens. Human Pathology 2008;39:610-5. [DOI: 10.1016/j.humpath.2007.09.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
41 Stearns ME, Wang M, Hu Y, Kim G, Garcia FU. Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4tΔ773–1081 overexpression is diagnostic for sentinel lymph node metastasis. Lab Invest 2004;84:785-95. [DOI: 10.1038/labinvest.3700075] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
42 Nordby Y, Andersen S, Richardsen E, Ness N, Al-Saad S, Melbø-Jørgensen C, Patel HR, Dønnem T, Busund LT, Bremnes RM. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy. Prostate 2015;75:1682-93. [PMID: 26268996 DOI: 10.1002/pros.23048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
43 Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: what do we know. Microsc Res Tech. 2003;60:171-180. [PMID: 12539171 DOI: 10.1002/jemt.10255] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
44 Franck Lissbrant, Erik Lissbrant, Jan-erik Damber, Anders Be I. Blood Vessels are Regulators of Growth, Diagnostic Markers and Therapeutic Targets in Prostate Cancer. Scandinavian Journal of Urology and Nephrology 2001;35:437-52. [DOI: 10.1080/003655901753367532] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
45 Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 2003;97:457-464. [PMID: 12518370 DOI: 10.1002/cncr.11073] [Cited by in Crossref: 115] [Cited by in F6Publishing: 101] [Article Influence: 6.4] [Reference Citation Analysis]
46 Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A, Ayala G. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate. 2004;58:193-199. [PMID: 14716745 DOI: 10.1002/pros.10321] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
47 Chevalier S, Defoy I, Lacoste J, Hamel L, Guy L, Bégin L, Aprikian A. Vascular endothelial growth factor and signaling in the prostate: more than angiogenesis. Molecular and Cellular Endocrinology 2002;189:169-79. [DOI: 10.1016/s0303-7207(01)00728-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
48 Pollina EA, Legesse-Miller A, Haley EM, Goodpaster T, Randolph-Habecker J, Coller HA. Regulating the angiogenic balance in tissues. Cell Cycle 2008;7:2056-70. [PMID: 18642446 DOI: 10.4161/cc.7.13.6240] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
49 Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 2002;16:922-934. [PMID: 12087053 DOI: 10.1096/fj.01-0945rev] [Cited by in Crossref: 208] [Cited by in F6Publishing: 181] [Article Influence: 10.9] [Reference Citation Analysis]
50 Kurihara M, Kirita T, Sasahira T, Ohmori H, Matsushima S, Yamamoto K, Bosserhoff AK, Kuniyasu H. Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma. Br J Cancer 2013;108:1460-9. [PMID: 23511560 DOI: 10.1038/bjc.2013.27] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
51 Kono M, Watanabe M, Abukawa H, Hasegawa O, Satomi T, Chikazu D. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma. J Oral Maxillofac Surg 2013;71:1694-702. [PMID: 23809761 DOI: 10.1016/j.joms.2013.04.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
52 Datta K, Muders M, Zhang H, Tindall DJ. Mechanism of lymph node metastasis in prostate cancer. Future Oncol 2010;6:823-36. [PMID: 20465393 DOI: 10.2217/fon.10.33] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
53 Choy M, Rafii S, Raffii S. Role of Angiogenesis in the Progression and Treatment of Prostate Cancer. Cancer Investigation 2001;19:181-91. [DOI: 10.1081/cnv-100000152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
54 Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 2004;95:32-39. [PMID: 14720324 DOI: 10.1111/j.1349-7006.2004.tb03167.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 103] [Article Influence: 6.8] [Reference Citation Analysis]
55 Cho HJ, Kim IK, Park SM, Baek KE, Nam IK, Park SH, Ryu KJ, Choi J, Ryu J, Hong SC. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Int J Cancer. 2014;135:1553-1563. [PMID: 24585459 DOI: 10.1002/ijc.28801] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
56 Petrillo A, Laterza MM, Tirino G, Pompella L, Pappalardo A, Ventriglia J, Savastano B, Auricchio A, Orditura M, Ciardiello F, Galizia G, De Vita F. Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients. J Gastrointest Oncol 2019;10:314-23. [PMID: 31032100 DOI: 10.21037/jgo.2018.12.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Mori R, Dorff TB, Xiong S, Tarabolous CJ, Ye W, Groshen S, Danenberg KD, Danenberg PV, Pinski JK. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes. Prostate 2010;70:1692-700. [PMID: 20564320 DOI: 10.1002/pros.21204] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
58 Park BK, Paik YH, Park JY, Park KH, Bang S, Park SW, Chung JB, Park YN, Song SY. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol. 2006;29:138-142. [PMID: 16601431 DOI: 10.1097/01.coc.0000204402.29830.08] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
59 Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967. [PMID: 17356953 DOI: 10.1245/s10434-006-9335-y] [Cited by in Crossref: 192] [Cited by in F6Publishing: 139] [Article Influence: 13.7] [Reference Citation Analysis]
60 Bhattacharjee RN, Timoshenko AV, Cai J, Lala PK. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer. Cancer Sci. 2010;101:2026-2032. [PMID: 20608938 DOI: 10.1111/j.1349-7006.2010.01647.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
61 Kubo H, Cao R, Brakenhielm E, Mäkinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA. 2002;99:8868-8873. [PMID: 12070340 DOI: 10.1073/pnas.062040199] [Cited by in Crossref: 216] [Cited by in F6Publishing: 183] [Article Influence: 11.4] [Reference Citation Analysis]
62 Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, Sugimachi K. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000;83:887-91. [PMID: 10970690 DOI: 10.1054/bjoc.2000.1396] [Cited by in Crossref: 155] [Cited by in F6Publishing: 169] [Article Influence: 7.4] [Reference Citation Analysis]
63 Amioka T, Kitadai Y, Tanaka S, Haruma K, Yoshihara M, Yasui W, Chayama K. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. European Journal of Cancer 2002;38:1413-9. [DOI: 10.1016/s0959-8049(02)00106-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
64 Yamamura A, Nayeem MJ, Muramatsu H, Nakamura K, Sato M. MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3. Front Pharmacol 2021;12:667474. [PMID: 33959030 DOI: 10.3389/fphar.2021.667474] [Reference Citation Analysis]
65 Li J, Wang E, Rinaldo F, Datta K. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 2005;24:5510-20. [DOI: 10.1038/sj.onc.1208693] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
66 He X, Yu X, Liu T, Yu S, Chen D. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice: . Chinese Medical Journal 2008;121:439-44. [DOI: 10.1097/00029330-200803010-00014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
67 Morita Y, Morita N, Hata K, Nakanishi M, Kimoto N, Omata T, Nakamura Y, Yoneda T. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:502-10. [PMID: 24560404 DOI: 10.1016/j.oooo.2013.12.410] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
68 Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech 2001;55:92-9. [PMID: 11596154 DOI: 10.1002/jemt.1160] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 6.3] [Reference Citation Analysis]
69 Wudel LJ Jr, Chapman WC. Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:77-90, ix. [PMID: 16843872 DOI: 10.1016/S1055-3207(02)00092-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Shimizu K, Kubo H, Yamaguchi K, Kawashima K, Ueda Y, Matsuo K, Awane M, Shimahara Y, Takabayashi A, Yamaoka Y. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci. 2004;95:328-333. [PMID: 15072591 DOI: 10.1111/j.1349-7006.2004.tb03211.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 6.3] [Reference Citation Analysis]
71 Goodyear S, Kheyfets S, Garcia F, Stearns M. Role of the VEGFR3/VEGFD receptor axis in TGFβ1 activation of primary prostate cell lines. Prostate 2009;69:982-90. [DOI: 10.1002/pros.20945] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
72 Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003;98:789-97. [PMID: 12910524 DOI: 10.1002/cncr.11583] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
73 Taghizadeh S, Sankian M, Ajami A, Tehrani M, Hafezi N, Mohammadian R, Farazmandfar T, Hosseini V, Abbasi A, Ajami M. Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer. J Gastric Cancer 2014;14:196-203. [PMID: 25328765 DOI: 10.5230/jgc.2014.14.3.196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
74 Kilicarslan AB, Ogus M, Arici C, Pestereli HE, Cakir M, Karpuzoglu G. Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas. APMIS 2003;111:439-43. [PMID: 12752224 DOI: 10.1034/j.1600-0463.2003.t01-1-1110209.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
75 Wu J, Yu E. Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy. Cancer Metastasis Rev 2014;33:607-17. [PMID: 24414227 DOI: 10.1007/s10555-013-9482-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
76 Fujimoto J, Toyoki H, Sato E, Sakaguchi H, Tamaya T. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004;91:466-9. [PMID: 15226772 DOI: 10.1038/sj.bjc.6601963] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
77 Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat. 2001;66:159-164. [PMID: 11437102 DOI: 10.1023/a:1010692132669] [Cited by in Crossref: 99] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
78 He X, Liu T, Xiao Y, Feng Y, Cheng D, Tingting G, Zhang L, Zhang Y, Chen Y, Tingting G, Zhang L. Vascular Endothelial Growth Factor-C siRNA Delivered via Calcium Carbonate Nanoparticle Effectively Inhibits Lymphangiogenesis and Growth of Colorectal Cancer In Vivo. Cancer Biotherapy and Radiopharmaceuticals 2009;24:249-59. [DOI: 10.1089/cbr.2008.0515] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
79 Matsumura M, Bhatt AS, Andress D, Clegg N, Takayama TK, Craik CS, Nelson PS. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 2005;62:1-13. [PMID: 15389820 DOI: 10.1002/pros.20101] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
80 Belkin DA, Mitsui H, Felsen D, Carucci JA. VEGF-C-producing macrophages in cutaneous squamous cell carcinoma. Expert Review of Dermatology 2014;6:643-51. [DOI: 10.1586/edm.11.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Mcwilliam L, Roberts I, Davies D. Problems in grading and staging prostatic carcinoma. Current Diagnostic Pathology 2002;8:65-75. [DOI: 10.1054/cdip.2001.0101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Salzman R, Stárek I, Kučerová L, Skálová A, Hoza J. Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma. Virchows Arch 2014;464:29-34. [PMID: 24233153 DOI: 10.1007/s00428-013-1502-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
83 Guo X, Chen L, Lang R, Fan Y, Zhang X, Fu L. Invasive Micropapillary Carcinoma of the Breast: Association of Pathologic Features With Lymph Node Metastasis. Am J Clin Pathol 2006;126:740-6. [DOI: 10.1309/axyy4ajtmnw6frmw] [Cited by in Crossref: 56] [Article Influence: 3.7] [Reference Citation Analysis]
84 Saito Y, Nakagami H, Kurooka M, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Morishita R, Azuma N, Sasajima T, Kaneda Y. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element. Oncogene 2008;27:1821-33. [DOI: 10.1038/sj.onc.1210824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
85 Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol. 2001;78:132-137. [PMID: 11579392 DOI: 10.1002/jso.1133] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 2.9] [Reference Citation Analysis]
86 Rinaldo F, Li J, Wang E, Muders M, Datta K. RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation. Oncogene 2007;26:1731-8. [PMID: 16964283 DOI: 10.1038/sj.onc.1209971] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
87 Yu J, Zhang X, Kuzontkoski PM, Jiang S, Zhu W, Li DY, Groopman JE. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway. Cell Commun Signal 2014;12:25. [PMID: 24708522 DOI: 10.1186/1478-811X-12-25] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
88 Singh B, Sahu PM, Lohiya RK, Sharma MK, Singh HL, Singh S. Anti-inflammatory activity of alkanoids and triterpenoids from Trichodesma amplexicaule Roth. Phytomedicine. 2006;13:152-156. [PMID: 16843872 DOI: 10.1016/j.phymed.2004.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
89 Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer. 2001;85:93-97. [PMID: 11437408 DOI: 10.1054/bjoc.2001.1846] [Cited by in Crossref: 98] [Cited by in F6Publishing: 111] [Article Influence: 4.9] [Reference Citation Analysis]
90 Byeon J, Jung H, Lee YJ, Lee D, Lee GH, Myung S, Yang S, Hong W, Kim J, Min YI, Kim JS. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2004;19:648-54. [DOI: 10.1111/j.1440-1746.2004.03348.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
91 Angeh JE, Huang X, Sattler I, Swan GE, Dahse H, Härtl A, Eloff JN. Antimicrobial and anti-inflammatory activity of four known and one new triterpenoid from Combretum imberbe (Combretaceae). J Ethnopharmacol. 2007;110:56-60. [PMID: 16843872 DOI: 10.1016/j.jep.2006.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
92 Nagata S, Aishima S, Fukuzawa K, Takagi H, Yonemasu H, Iwashita Y, Kinoshita T, Wakasugi K. Adenomatoid tumour of the liver. J Clin Pathol. 2008;61:777-780. [PMID: 16843872 DOI: 10.1136/jcp.2007.054684] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
93 Li Y, Cozzi PJ. Angiogenesis as a strategic target for prostate cancer therapy. Med Res Rev 2010;30:23-66. [PMID: 19536866 DOI: 10.1002/med.20161] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
94 He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 2004;1654:3-12. [PMID: 14984763 DOI: 10.1016/j.bbcan.2003.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 49] [Article Influence: 0.7] [Reference Citation Analysis]
95 Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673-700. [PMID: 12087132 DOI: 10.1152/physrev.00005.2002] [Cited by in Crossref: 269] [Cited by in F6Publishing: 231] [Article Influence: 14.2] [Reference Citation Analysis]
96 Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107-1115. [PMID: 16843872 DOI: 10.1242/jeb.00220] [Cited by in Crossref: 389] [Cited by in F6Publishing: 370] [Article Influence: 25.9] [Reference Citation Analysis]
97 Yan L, Zhu Z. Development of antibody-based therapeutics for oncology indications. Drug Dev Res 2006;67:699-728. [DOI: 10.1002/ddr.20146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Delvaux V, Sciot R, Neuville B, Moerman P, Peeters M, Filez L, Van Beckevoort D, Ectors N, Geboes K. Multifocal epithelioid angiosarcoma of the small intestine. Virchows Arch. 2000;437:90-94. [PMID: 10963385 DOI: 10.1007/s004280000183] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
99 Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 2003;278:5750-9. [PMID: 12471041 DOI: 10.1074/jbc.M204863200] [Cited by in Crossref: 110] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
100 Terada T, Ohta T, Nakanuma Y. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas. Histopathology. 1996;29:355-361. [PMID: 16843872 DOI: 10.1111/j.1365-2559.1996.tb01419.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
101 Fujimiya M, Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides. 2000;21:1565-1582. [PMID: 16843872 DOI: 10.1016/S0196-9781(00)00313-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
102 Sun H, Tang F, Zhou S, Li X, Wang S, Huang K, Jia Y, Tian X, Ma D, Li S. Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: A meta-analysis. J Obstet Gynaecol Res 2016;42:1310-6. [PMID: 27334572 DOI: 10.1111/jog.13064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
103 Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg. 2002;137:447-451. [PMID: 16843872 DOI: 10.1001/archsurg.137.4.447] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
104 Wang XY, Gao F, Sun YR, Bai LL, Ibrahim MM, Wang B, Tang JW. In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms. Tumour Biol 2016;37:911-24. [PMID: 26256045 DOI: 10.1007/s13277-015-3691-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
105 Balanathan P, Williams ED, Wang H, Pedersen JS, Horvath LG, Achen MG, Stacker SA, Risbridger GP. Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer. Br J Cancer 2009;100:1784-93. [PMID: 19436293 DOI: 10.1038/sj.bjc.6605089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
106 He XW, Liu T, Chen YX, Cheng DJ, Li XR, Xiao Y, Feng YL. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther. 2008;15:193-202. [PMID: 18202713 DOI: 10.1038/sj.cgt.7701122] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
107 Thomas LN, Merrimen J, Bell DG, Rendon R, Goffin V, Too CKL. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting: The Role of CPD in Prostate Cancer. Prostate 2014;74:732-42. [DOI: 10.1002/pros.22793] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
108 Xu LL, Li ZJ, Niu XL, Deng WM. The mechanisms of IL-17A on promoting tumor metastasis. Int Rev Immunol 2017;36:360-9. [PMID: 28933960 DOI: 10.1080/08830185.2017.1356296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198. [PMID: 11175850 DOI: 10.1038/84643] [Cited by in Crossref: 1193] [Cited by in F6Publishing: 1046] [Article Influence: 59.7] [Reference Citation Analysis]
110 Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology. 2006;43:373-374; author reply 375-376. [PMID: 16843872 DOI: 10.1002/hep.21019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
111 Brown CJ, Falck VG, MacLean A. Angiosarcoma of the colon and rectum: report of a case and review of the literature. DisColon Rectum. 2004;47:2202-2207. [PMID: 16843872 DOI: 10.1007/s10350-004-0698-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
112 Sharma R, Rajasekar MR, Raghuvanshi A. Immunosuppresion strategies after liver transplantation: a single centre experience in 57 liver transplan recipients. Indian J Surg. 2007;69:187-190. [PMID: 16843872 DOI: 10.1007/s12262-007-0018-0] [Reference Citation Analysis]
113 Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 2004;172:103-7. [PMID: 15201747 DOI: 10.1097/01.ju.0000128860.00639.9c] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
114 Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413-423. [PMID: 12872364 DOI: 10.1002/cncr.11464] [Cited by in Crossref: 272] [Cited by in F6Publishing: 234] [Article Influence: 16.0] [Reference Citation Analysis]
115 Seyed Jafari SM, Wiedmer C, Cazzaniga S, Frangež Ž, Shafighi M, Beltraminelli H, Weber B, Simon HU, Hunger RE. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis. PLoS One 2018;13:e0207019. [PMID: 30408085 DOI: 10.1371/journal.pone.0207019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
116 Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2005;12:152-158. [PMID: 15733109 DOI: 10.1111/j.1442-2042.2005.01010.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
117 Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, Takase K, Nakano T. High expression of CD34- positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol. 2001;32:1363-1370. [PMID: 16843872 DOI: 10.1053/hupa.2001.29678] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
118 Papoutsi M, Sleeman JP, Wilting J. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane. Microsc Res Tech 2001;55:100-7. [DOI: 10.1002/jemt.1161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
119 Hoza J, Salzman R, Bakaj T, Kucerova L, Starek I. Comparison of lymphatic vessel density and expression of VEGF-C and VEGF-D lymphangiogenic factors in Warthin's tumours and oncocytic adenomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:47-53. [DOI: 10.5507/bp.2017.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Abe N, Ohtake T, Saito K, Kumamoto K, Sugino T, Takenoshita S. Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer. Fukushima J Med Sci 2016;62:57-63. [PMID: 27210308 DOI: 10.5387/fms.2015-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
121 Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T, Naito Z. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol. 2005;78:123-130. [PMID: 15713437 DOI: 10.1016/j.yexmp.2004.11.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
122 Sun Z, Wang Z, Zhang M. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy: VEGF-C and ESCC. Asia-Pacific Journal of Clinical Oncology 2012;8:e68-76. [DOI: 10.1111/j.1743-7563.2011.01514.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Kajita T, Ohta Y, Kimura K, Tamura M, Tanaka Y, Tsunezuka Y, Oda M, Sasaki T, Watanabe G. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 2001;85:255-60. [PMID: 11461086 DOI: 10.1054/bjoc.2001.1882] [Cited by in Crossref: 119] [Cited by in F6Publishing: 130] [Article Influence: 6.0] [Reference Citation Analysis]
124 Zhao B, Smith G, Cai J, Ma A, Boulton M. Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2. Br J Ophthalmol 2007;91:538-45. [PMID: 16943230 DOI: 10.1136/bjo.2006.101543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
125 Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Current Opinion in Biotechnology 1999;10:528-38. [DOI: 10.1016/s0958-1669(99)00024-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
126 Haider T, Sandha KK, Soni V, Gupta PN. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models. Materials Science and Engineering: C 2020;116:111229. [DOI: 10.1016/j.msec.2020.111229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
127 Bevilacqua S, Gallo M, Franco R, Rossi A, De Luca A, Rocco G, Botti G, Gridelli C, Normanno N. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer. 2009;65:123-125. [PMID: 16843872 DOI: 10.1634/10.1016/j.lungcan.2009.01.019] [Reference Citation Analysis]
128 Chaudary N, Milosevic M, Hill RP. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol Oncol 2011;123:393-400. [PMID: 21839498 DOI: 10.1016/j.ygyno.2011.07.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
129 Zoli M, Magalotti D, Giampaolo B, Gino G, Orlandini C, Grimaldi M, Marchesini G, Pisi E. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. Journal of Hepatology 1995;23:129-34. [DOI: 10.1016/0168-8278(95)80326-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 1.8] [Reference Citation Analysis]
130 Zimmerman RL, Burke MA, Young NA, Solomides CC, Bibbo M. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-91. [DOI: 10.1002/cncr.9043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
131 Jennbacken K, Vallbo C, Wang W, Damber J. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 2005;65:110-6. [DOI: 10.1002/pros.20276] [Cited by in Crossref: 95] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
132 Van Trappen PO, Pepper MS. Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol. 2002;3:44-52. [PMID: 11905605 DOI: 10.1016/s1470-2045(01)00621-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
133 Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery. 2003;133:300-308. [PMID: 12660643 DOI: 10.1067/msy.2003.45] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
134 Beierle EA, Dai W, Langham MR Jr, Copeland EM 3rd, Chen MK. Expression of VEGF receptors in cocultured neuroblastoma cells. J Surg Res. 2004;119:56-65. [PMID: 15126083 DOI: 10.1016/j.jss.2004.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
135 Di J, Zhou J, Zhou X, Gao X, Shao C, Pang J, Sun Q, Zhang Y, Ruan X. Cyclooxygenase-2 Expression Is Associated with Vascular Endothelial Growth Factor-C and Lymph Node Metastases in Human Prostate Cancer. Archives of Medical Research 2009;40:268-75. [DOI: 10.1016/j.arcmed.2009.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
136 Sutcliffe R, Maguire D, Murphy P, Portmann B, Rela M, O'Sullivan G, Mufti G, Heaton N. Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma. Transplantation. 2005;80:88-94. [PMID: 16843872 DOI: 10.1097/01.TP.0000164499.40952.C8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Yang S, Han H. Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells. Oncol Lett 2014;8:1628-34. [PMID: 25202381 DOI: 10.3892/ol.2014.2395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
138 Pazgal I, Boycov O, Shpilberg O, Okon E, Bairey O. Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas. Leukemia & Lymphoma 2009;48:2213-20. [DOI: 10.1080/10428190701632822] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
139 Soumaoro LT, Uetake H, Takagi Y, Iida S, Higuchi T, Yasuno M, Enomoto M, Sugihara K. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis. Dis Colon Rectum 2006;49:392-8. [PMID: 16474989 DOI: 10.1007/s10350-005-0247-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
140 Kato S, Shimoda H, Ji RC, Miura M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 2006;81:71-83. [PMID: 16800291 DOI: 10.1111/j.1447-073X.2006.00142.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
141 Niki T, Iba S, Yamada T, Matsuno Y, Enholm B, Hirohashi S. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol 2001;193:450-7. [PMID: 11276003 DOI: 10.1002/path.828] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
142 Yavuz S, Paydas S, Disel U, Zorludemir S, Erdogan S. VEGF-C expression in breast cancer: clinical importance. Adv Ther 2005;22:368-80. [PMID: 16418144 DOI: 10.1007/BF02850084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
143 Liu XE, Sun XD, Wu JM. Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol. 2004;10:352-355. [PMID: 14760756 DOI: 10.3748/wjg.v10.i3.352] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
144 Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054-8. [DOI: 10.1038/sj.leu.2403355] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
145 Straume O, Akslen LA. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. Am J Pathol. 2002;160:1009-1019. [PMID: 11891198 DOI: 10.1016/s0002-9440(10)64922-x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
146 Schlereth SL, Refaian N, Iden S, Cursiefen C, Heindl LM. Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis. Biomed Res Int. 2014;2014:639058. [PMID: 25254213 DOI: 10.1155/2014/639058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
147 Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998;33:318-324. [PMID: 16843872 DOI: 10.1046/j.1365-2559.1998.00522.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
148 Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol. 2006;19:392-398. [PMID: 16400321 DOI: 10.1038/modpathol.3800546] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
149 Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000;14:2087-2096. [PMID: 11023993 DOI: 10.1096/fj.99-1049com] [Cited by in Crossref: 226] [Cited by in F6Publishing: 206] [Article Influence: 10.8] [Reference Citation Analysis]
150 Clarijs R, Ruiter DJ, de Waal RMW. Lymphangiogenesis in malignant tumours: does it occur? J Pathol 2001;193:143-6. [DOI: 10.1002/path.808] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 3.5] [Reference Citation Analysis]
151 Beecken W, Bentas W, Glienke W, Linneweber J, Jonas D, Binder J, Kramer W. Serum Angiogenic Activity: Diagnostic Relevance in Renal Cell Carcinoma. European Urology 2002;42:364-9. [DOI: 10.1016/s0302-2838(02)00359-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
152 Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP, Jacobs IJ. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 2003;201:544-54. [PMID: 14648657 DOI: 10.1002/path.1467] [Cited by in Crossref: 94] [Cited by in F6Publishing: 76] [Article Influence: 5.5] [Reference Citation Analysis]
153 Maitland NJ. The Search for Genes Which Influence Prostate Cancer Metastasis: A Moving Target? In: Ablin RJ, Mason MD, editors. Metastasis of Prostate Cancer. Dordrecht: Springer Netherlands; 2007. pp. 21-61. [DOI: 10.1007/978-1-4020-5847-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Zhang H, Muders MH, Li J, Rinaldo F, Tindall DJ, Datta K. Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer. Cancer Res 2008;68:8770-8. [PMID: 18974119 DOI: 10.1158/0008-5472.CAN-08-1912] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
155 Takei Y, Okumura S, Nagal H. TNF-α induced apoptosis of hepatocyte precedes massive hepatic necrosis during the cause of acute hepatitis failure. Hepatology. 1995;22:380-390. [PMID: 16843872 DOI: 10.1016/0270-9139(95)95240-3] [Reference Citation Analysis]
156 Homer J, Greenman J, Stafford N. The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: relationship with radioresistance. Clin Otolaryngol 2001;26:498-504. [DOI: 10.1046/j.1365-2273.2001.00512.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
157 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
158 Majumder M, Xin X, Lala PK. A practical and sensitive method of quantitating lymphangiogenesis in vivo. Lab Invest 2013;93:779-91. [PMID: 23711825 DOI: 10.1038/labinvest.2013.72] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
159 Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005;103:724-730. [PMID: 15637689 DOI: 10.1002/cncr.20819] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
160 Koshida K, Konaka H, Imao T, Egawa M, Mizokami A, Namiki M. Comparison of two in vivo models for prostate cancer: orthotopic and intratesticular inoculation of LNCaP or PC-3 cells. Int J Urol 2004;11:1114-21. [PMID: 15663685 DOI: 10.1111/j.1442-2042.2004.00961.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
161 Stacker SA, Williams RA, Achen MG. Lymphangiogenic growth factors as markers of tumor metastasis. APMIS. 2004;112:539-549. [PMID: 15563315 DOI: 10.1111/j.1600-0463.2004.apm11207-0812.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
162 Shin WS, Rockson SG. Lymphangiogenesis: Recapitulation of Angiogensis in Health and Disease. In: Forough R, editor. New Frontiers in Angiogenesis. Dordrecht: Springer Netherlands; 2006. pp. 159-202. [DOI: 10.1007/1-4020-4327-9_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
163 Tuomela JM, Valta MP, Väänänen K, Härkönen PL. Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. BMC Cancer. 2008;8:81. [PMID: 18371232 DOI: 10.1186/1471-2407-8-81] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
164 Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131:225-234. [PMID: 18519975 DOI: 10.1196/annals.1413.020] [Cited by in Crossref: 172] [Cited by in F6Publishing: 143] [Article Influence: 13.2] [Reference Citation Analysis]
165 Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2008;37:372-8. [PMID: 18295452 DOI: 10.1016/j.ijom.2007.11.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
166 Kito Y, Suzuki H. Electrophysiological properties of gastric pacemaker potentials. J Smooth Muscle Res. 2003;39:163-173. [PMID: 16843872 DOI: 10.1540/jsmr.39.163] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
167 Lin YC, Chen CC, Chen WM, Lu KY, Shen TL, Jou YC, Shen CH, Ohbayashi N, Kanaho Y, Huang YL, Lee H. LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:1305-15. [PMID: 30053596 DOI: 10.1016/j.bbalip.2018.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
168 Paydas S, Seydaoglu G, Ergin M, Erdogan S, Yavuz S. The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. Leuk Lymphoma 2009;50:366-73. [PMID: 19347725 DOI: 10.1080/10428190802706665] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
169 Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W, Chayama K. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93:662-666. [PMID: 11477575 DOI: 10.1002/ijc.1379] [Cited by in Crossref: 130] [Cited by in F6Publishing: 146] [Article Influence: 6.5] [Reference Citation Analysis]
170 O-charoenrat P, Rhys-evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92:556-68. [DOI: 10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>3.0.co;2-q] [Cited by in Crossref: 154] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
171 Kuo CJ, Farnebo FA, Becker CM, Folkman J. VEGF-Targeted Antiangiogenic Gene Therapy. Gene Therapy of Cancer. Elsevier; 2002. pp. 421-34. [DOI: 10.1016/b978-012437551-2/50028-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000;19:6122-9. [DOI: 10.1038/sj.onc.1203969] [Cited by in Crossref: 169] [Cited by in F6Publishing: 144] [Article Influence: 8.0] [Reference Citation Analysis]
173 Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Umemoto M, Sakamoto T, Sato S. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer. 2003;88:237-244. [PMID: 12610509 DOI: 10.1038/sj.bjc.6600701] [Cited by in Crossref: 107] [Cited by in F6Publishing: 123] [Article Influence: 5.9] [Reference Citation Analysis]
174 Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161:947-956. [PMID: 12213723 DOI: 10.1016/s0002-9440(10)64255-1] [Cited by in Crossref: 534] [Cited by in F6Publishing: 237] [Article Influence: 28.1] [Reference Citation Analysis]
175 Brakenhielm E, Burton JB, Johnson M, Chavarria N, Morizono K, Chen I, Alitalo K, Wu L. Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int J Cancer 2007;121:2153-61. [PMID: 17583576 DOI: 10.1002/ijc.22900] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
176 Karpanen T, Alitalo K. Lymphatic vessels as targets of tumor therapy? J Exp Med 2001;194:F37-42. [PMID: 11561002 DOI: 10.1084/jem.194.6.f37] [Cited by in Crossref: 88] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
177 Ishikawa M, Kitayama J, Kazama S, Nagawa H. Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma. World J Surg Oncol 2005;3:2. [PMID: 15636643 DOI: 10.1186/1477-7819-3-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
178 Hokari R, Kitagawa N, Watanabe C, Komoto S, Kurihara C, Okada Y, Kawaguchi A, Nagao S, Hibi T, Miura S. Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss. J Gastroenterol Hepatol. 2008;23:e88-e95. [PMID: 18005011 DOI: 10.1111/j.1440-1746.2007.05225.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
179 Smith JA, Bhathal PS, Cuthbertson AM. Angiosarcoma of the colon. Report of a case with long-term survival. Dis Colon Rectum. 1990;33:330-333. [PMID: 16843872 DOI: 10.1007/BF02055479] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
180 Srisomsap C, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J. Proteomic analysis of cholangiocarcinoma cell line. Proteomics. 2004;4:1135-1144. [PMID: 15048994 DOI: 10.1002/pmic.200300651] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
181 Tamura M, Ohta Y. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Cancer. 2003;98:1217-1222. [PMID: 12973845 DOI: 10.1002/cncr.11529] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
182 Cassella M, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci. 2002;979:120-130. [PMID: 12543722 DOI: 10.1111/j.1749-6632.2002.tb04873.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
183 Ding MX, Lin XQ, Fu XY, Zhang N, Li JC. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma. World J Gastroenterol. 2006;12:4582-4585. [PMID: 16874878 DOI: 10.3748/wjg.v12.i28.4582] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
184 Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, Sano K, Fujimori M, Amano J, Ohhashi T, Kannagi R, Kimata K, Taniguchi S, Itano N. Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 2008;172:179-93. [PMID: 18079437 DOI: 10.2353/ajpath.2008.070360] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
185 Lee CY, Tien HF, Hu CY, Chou WC, Lin LI. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Br J Cancer 2007;97:877-82. [PMID: 17848952 DOI: 10.1038/sj.bjc.6603966] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
186 Ishikawa K, Komuro T, Hirota S, Kitamura Y. Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws/Ws mutant rats. Cell Tissue Res. 1997;289:137-143. [PMID: 16843872 DOI: 10.1007/s004410050859] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
187 Stárek I, Salzman R, Kučerová L, Skálová A, Hauer L. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma. Pathology - Research and Practice 2015;211:759-65. [DOI: 10.1016/j.prp.2015.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
188 Thiele W, Sleeman JP. Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol. 2006;124:224-241. [PMID: 16497404 DOI: 10.1016/j.jbiotec.2006.01.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
189 Israel DA, Peek RM Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol. 2006;22:3-7. [PMID: 16843872 DOI: 10.1097/01.mog.0000194790.51714.f0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
190 Nassar ZD, Hill MM, Parton RG, Francois M, Parat MO. Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis. Oncoscience 2015;2:635-45. [PMID: 26328273 DOI: 10.18632/oncoscience.180] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
191 Delongchamps NB, Peyromaure M, Dinh-Xuan AT. Role of vascular endothelial growth factor in prostate cancer. Urology 2006;68:244-8. [PMID: 16904427 DOI: 10.1016/j.urology.2006.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
192 Beierle EA, Dai W, Langham MR, Copeland EM, Chen MK. VEGF receptors are differentially expressed by neuroblastoma cells in culture. Journal of Pediatric Surgery 2003;38:514-21. [DOI: 10.1053/jpsu.2003.50091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
193 Liu S, Han B, Zhang Q, Dou J, Wang F, Lin W, Sun Y, Peng G. Vasohibin-1 suppresses colon cancer. Oncotarget 2015;6:7880-98. [PMID: 25797264 DOI: 10.18632/oncotarget.3493] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
194 Ishikawa M, Kitayama J, Kazama S, Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol. 2003;33:21-27. [PMID: 12604720 DOI: 10.1093/jjco/hyg008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
195 Dobashi A, Imazu H, Tatsumi N, Okabe M, Ang TL, Tajiri H. Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography. Scandinavian Journal of Gastroenterology 2013;48:848-55. [DOI: 10.3109/00365521.2013.800990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
196 Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001;20:672-682. [PMID: 11179212 DOI: 10.1093/emboj/20.4.672] [Cited by in Crossref: 646] [Cited by in F6Publishing: 592] [Article Influence: 32.3] [Reference Citation Analysis]
197 Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-583. [PMID: 12154350 DOI: 10.1038/nrc863] [Cited by in Crossref: 561] [Cited by in F6Publishing: 471] [Article Influence: 29.5] [Reference Citation Analysis]
198 Hinson AM, Massoll NA, Jolly LA, Stack BC Jr, Bodenner DL, Franco AT. Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis. Head Neck 2017;39:1639-46. [PMID: 28467685 DOI: 10.1002/hed.24807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
199 Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol. 2004;28:298-307. [PMID: 15104292 DOI: 10.1097/00000478-200403000-00002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
200 Zhao B, Ma A, Cai J, Boulton M. VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells. Br J Ophthalmol 2006;90:1052-9. [PMID: 16687456 DOI: 10.1136/bjo.2006.091215] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
201 Tuomela J, Valta M, Seppänen J, Tarkkonen K, Väänänen HK, Härkönen P. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer. 2009;9:362. [PMID: 19821979 DOI: 10.1186/1471-2407-9-362] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
202 Takeda H, Yamakawa M, Takahashi T, Imai Y, Ishikawa M. An immunohistochemical study with an estrogen receptor- related protein (ER-D5) in human colorectal cancer. Cancer. 1992;69:907-912. [PMID: 16843872 DOI: 10.1002/1097-0142(19920215)69:4%3C907::AID-CNCR2820690412%3E3.0.CO;2-L] [Reference Citation Analysis]
203 Kanda S, Miyata Y, Kanetake H. Current status and perspective of antiangiogenic therapy for cancer: urinary cancer. Int J Clin Oncol 2006;11:90-107. [DOI: 10.1007/s10147-006-0565-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
204 Li J, Hong M, Pan T. Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer. J Huazhong Univ Sci Technolog Med Sci 2006;26:587-90. [PMID: 17219976 DOI: 10.1007/s11596-006-0528-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
205 Xia X, Liu K, Zhang H, Shang Z. Correlation between CCR 7 expression and lymph node metastatic potential of human tongue carcinoma. Oral Dis 2015;21:123-31. [DOI: 10.1111/odi.12228] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]